For Immediate Release

Chicago, IL - April 9, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: GlaxoSmithKline plc (GSK), General Growth Properties (GGP), Agria Corp (GRO), Regis Corporation (RGS) and Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Wednesday's Analyst Blog:

Glaxo's Avandia Issue Priced-In

Sales of Avandia have been significantly negatively impacted due to safety concerns, but it appears they have recently stabilized. We believe that sales are now at, or very near, their bottom. While sales of Avandia have been

...

Sales Decline at Sell-Rated Regis Corp. (RGS)If you happen to be a fan of long hair, the economic recession has some upside for you. With consumers looking to cut back on expenditures wherever they can, it seems that delaying their next haircut might be a popular option.Sell-rated Regis Corporation (RGS), the largest beauty salon company in the country, announced this morning that third quarter revenues declined 2.5% versus the prior year. Excluding the deconsolidation of its European salon operations, revenues would have been down 1.7%.More importantly, in our opinion, is the fact that same-store-sales decreased 4.5% year-over-year.The company recently opted to divest its Trade Secret brand, which had been posting the largest same-store-sale declines of any chain in the company's portfolio. Absent this divestiture, same-store-sales would likely have been down even further.With more than 12,800 system-wide locations ...

Martek Bioscience (MATK) announced in September that made it a multiple license and supply deal with an international food companies, Hero, Grupo Ricap, and Hochdorf Nutricare. Martek will supply all of companies' ARA and DHA for infant formula and children's food and milk, specially designed for a child's early life.

The deal allows Martek to continue its international expansion into Mexico, Europe, and China. Martek's proprietary DHA and ARA blend is used in approximately 95% of infant formulas sold in the U.S.

On Sep 4 Martek announced third-quarter earnings that included earnings per share of 28 cents. This market the fourth surprise in the past 4 quarters, as analysts were only expecting 24 cents. Revenues rose 14% year-over-year to $88.4 million.

Martek also raised full-year guidance during the announcement. The company expects earnings per share to be between $1.06 and $1.09,

...

Perfumania Holdings (PERF) operates as a wholesaler and retailer of designer perfume and fragrances. The company also offers bath aides and skin care products for men, women and children. Perfumania primarily markets its products through the Web site Perfumania.com. On Friday, the company warned investors same-store sales and earnings for October 2008 will fail to meet expectations due to a weak U.S. economy. The company also said it will reduce the number of new stores it opens in 2009. Perfumania opened 56 new stores in fiscal 2008.

Slumping sales in August and September, inventory reductions at the company’s recently acquired Model Reorg business, and lower orders from important customers dampened Perfumania’s second quarter results. For the first seven weeks of the third quarter, Perfumania’s same store sales are off by about three percent, the New York-based company said. For the second quarter, Perfumania posted a loss of $2 million, or 65

...